Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Centre Hospitalier Universitaire Vaudois
National Cancer Centre, Singapore
Changchun GeneScience Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Minneamrita Therapeutics LLC
Lebanese University
Amsterdam UMC, location VUmc
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
National University Hospital, Singapore
Jiangsu HengRui Medicine Co., Ltd.
Impact Therapeutics, Inc.
Biocad
Shanghai Proton and Heavy Ion Center
Genzada Pharmaceuticals USA, Inc.
TYK Medicines, Inc
Provectus Pharmaceuticals
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Imperial College London
Silverback Therapeutics
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Universitair Ziekenhuis Brussel
National Taiwan University Hospital Hsin-Chu Branch
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Zhejiang Provincial People's Hospital
Hoffman Oncology
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
ISU Abxis Co., Ltd.
Peking University Cancer Hospital & Institute
UMC Utrecht
Hengrui Therapeutics, Inc.
Mansoura University
Klaipėda University
Al-Azhar University
Taizhou EOC Pharma Co., Ltd.
Placon Therapeutics
Jiangsu T-Mab Biopharma Co.,Ltd
Mansoura University
Qilu Pharmaceutical Co., Ltd.
Jiangsu T-Mab Biopharma Co.,Ltd
Jiangsu T-Mab Biopharma Co.,Ltd
Fudan University
Southwest Hospital, China
Wuxi No. 4 People's Hospital
R-Pharm
Merrimack Pharmaceuticals
Rigshospitalet, Denmark
Shenzhen Second People's Hospital
Women's College Hospital
Peking Union Medical College Hospital